COVID-19 Impact on Prostate Cancer Drugs Market, Global Research Reports 2020-2021

Publisher Name :
Date: 29-May-2020
No. of pages: 102
Inquire Before Buying

This report covers market size and forecasts of Prostate Cancer Drugs, including the following market information:

  • Global Prostate Cancer Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

  • Global Prostate Cancer Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

  • Global Prostate Cancer Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

  • Global Prostate Cancer Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

Key market players

Major competitors identified in this market include AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis, Amgen, Bayer HealthCare, Ferring Pharmaceutical, Janssen Pharmaceuticals, Endo Pharmaceuticals, BMS, Takeda Pharmaceuticals, Northwest Biotherapeutics, Teva Pharmaceutical, Boehringer Ingelheim, Foresee Pharmaceuticals, Tokai Pharmaceuticals, Spectrum Pharmaceuticals, etc.

Based on the Region:

  • Asia-Pacific (China, Japan, South Korea, India and ASEAN)

  • North America (US and Canada)

  • Europe (Germany, France, UK and Italy)

  • Rest of World (Latin America, Middle East & Africa)

Based on the Type:

  • Hormonal Therapy

  • Chemotherapy

  • Immunotherapy

  • Targeted Therapy

Based on the Application:

  • Clinics

  • Hospitals

  • Other

COVID-19 Impact on Prostate Cancer Drugs Market, Global Research Reports 2020-2021

Table of Contents
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Prostate Cancer Drugs Industry
1.7 COVID-19 Impact: Prostate Cancer Drugs Market Trends
2 Global Prostate Cancer Drugs Quarterly Market Size Analysis
2.1 Prostate Cancer Drugs Business Impact Assessment - COVID-19
2.1.1 Global Prostate Cancer Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Prostate Cancer Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Prostate Cancer Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Prostate Cancer Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Prostate Cancer Drugs Factory Price by Manufacturers
3.3 Location of Key Manufacturers Prostate Cancer Drugs Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Prostate Cancer Drugs Market
3.5 Key Manufacturers Prostate Cancer Drugs Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Prostate Cancer Drugs Segments, By Type
4.1 Introduction
1.4.1 Hormonal Therapy
1.4.2 Chemotherapy
1.4.3 Immunotherapy
1.4.4 Targeted Therapy
4.2 By Type, Global Prostate Cancer Drugs Market Size, 2019-2021
4.2.1 By Type, Global Prostate Cancer Drugs Market Size by Type, 2020-2021
4.2.2 By Type, Global Prostate Cancer Drugs Price, 2020-2021
5 Impact of Covid-19 on Prostate Cancer Drugs Segments, By Application
5.1 Overview
5.5.1 Clinics
5.5.2 Hospitals
5.5.3 Other
5.2 By Application, Global Prostate Cancer Drugs Market Size, 2019-2021
5.2.1 By Application, Global Prostate Cancer Drugs Market Size by Application, 2019-2021
5.2.2 By Application, Global Prostate Cancer Drugs Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.1.3 AbbVie Prostate Cancer Drugs Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Business Overview
7.2.2 Astellas Pharma Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.2.3 Astellas Pharma Prostate Cancer Drugs Product Introduction
7.2.4 Astellas Pharma Response to COVID-19 and Related Developments
7.3 Astra Zeneca
7.3.1 Astra Zeneca Business Overview
7.3.2 Astra Zeneca Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.3.3 Astra Zeneca Prostate Cancer Drugs Product Introduction
7.3.4 Astra Zeneca Response to COVID-19 and Related Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Business Overview
7.4.2 Johnson & Johnson Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.4.3 Johnson & Johnson Prostate Cancer Drugs Product Introduction
7.4.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.5 Sanofi
7.5.1 Sanofi Business Overview
7.5.2 Sanofi Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.5.3 Sanofi Prostate Cancer Drugs Product Introduction
7.5.4 Sanofi Response to COVID-19 and Related Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Business Overview
7.6.2 GlaxoSmithKline Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Product Introduction
7.6.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.7 Merck Group
7.7.1 Merck Group Business Overview
7.7.2 Merck Group Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.7.3 Merck Group Prostate Cancer Drugs Product Introduction
7.7.4 Merck Group Response to COVID-19 and Related Developments
7.8 Novartis
7.8.1 Novartis Business Overview
7.8.2 Novartis Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.8.3 Novartis Prostate Cancer Drugs Product Introduction
7.8.4 Novartis Response to COVID-19 and Related Developments
7.9 Amgen
7.9.1 Amgen Business Overview
7.9.2 Amgen Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.9.3 Amgen Prostate Cancer Drugs Product Introduction
7.9.4 Amgen Response to COVID-19 and Related Developments
7.10 Bayer HealthCare
7.10.1 Bayer HealthCare Business Overview
7.10.2 Bayer HealthCare Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.10.3 Bayer HealthCare Prostate Cancer Drugs Product Introduction
7.10.4 Bayer HealthCare Response to COVID-19 and Related Developments
7.11 Ferring Pharmaceutical
7.11.1 Ferring Pharmaceutical Business Overview
7.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Product Introduction
7.11.4 Ferring Pharmaceutical Response to COVID-19 and Related Developments
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Business Overview
7.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Product Introduction
7.12.4 Janssen Pharmaceuticals Response to COVID-19 and Related Developments
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Business Overview
7.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Product Introduction
7.13.4 Endo Pharmaceuticals Response to COVID-19 and Related Developments
7.14 BMS
7.14.1 BMS Business Overview
7.14.2 BMS Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.14.3 BMS Prostate Cancer Drugs Product Introduction
7.14.4 BMS Response to COVID-19 and Related Developments
7.15 Takeda Pharmaceuticals
7.15.1 Takeda Pharmaceuticals Business Overview
7.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Product Introduction
7.15.4 Takeda Pharmaceuticals Response to COVID-19 and Related Developments
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Business Overview
7.16.2 Northwest Biotherapeutics Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Product Introduction
7.16.4 Northwest Biotherapeutics Response to COVID-19 and Related Developments
7.17 Teva Pharmaceutical
7.17.1 Teva Pharmaceutical Business Overview
7.17.2 Teva Pharmaceutical Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.17.3 Teva Pharmaceutical Prostate Cancer Drugs Product Introduction
7.17.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Business Overview
7.18.2 Boehringer Ingelheim Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.18.3 Boehringer Ingelheim Prostate Cancer Drugs Product Introduction
7.18.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
7.19 Foresee Pharmaceuticals
7.19.1 Foresee Pharmaceuticals Business Overview
7.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Product Introduction
7.19.4 Foresee Pharmaceuticals Response to COVID-19 and Related Developments
7.20 Tokai Pharmaceuticals
7.20.1 Tokai Pharmaceuticals Business Overview
7.20.2 Tokai Pharmaceuticals Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Product Introduction
7.20.4 Tokai Pharmaceuticals Response to COVID-19 and Related Developments
7.21 Spectrum Pharmaceuticals
7.21.1 Spectrum Pharmaceuticals Business Overview
7.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Quarterly Production and Revenue, 2020
7.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Introduction
7.21.4 Spectrum Pharmaceuticals Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Prostate Cancer Drugs Supply Chain Analysis
8.1.1 Prostate Cancer Drugs Supply Chain Analysis
8.1.2 Covid-19 Impact on Prostate Cancer Drugs Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Prostate Cancer Drugs Distribution Channels
8.2.2 Covid-19 Impact on Prostate Cancer Drugs Distribution Channels
8.2.3 Prostate Cancer Drugs Distributors
8.3 Prostate Cancer Drugs Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of Tables

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Prostate Cancer Drugs Assessment
Table 9. COVID-19 Impact: Prostate Cancer Drugs Market Trends
Table 10. COVID-19 Impact Global Prostate Cancer Drugs Market Size
Table 11. Global Prostate Cancer Drugs Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Prostate Cancer Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Prostate Cancer Drugs Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Prostate Cancer Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Prostate Cancer Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Prostate Cancer Drugs Market Growth Drivers
Table 17. Global Prostate Cancer Drugs Market Restraints
Table 18. Global Prostate Cancer Drugs Market Opportunities
Table 19. Global Prostate Cancer Drugs Market Challenges
Table 20. Key Manufacturers Prostate Cancer Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Prostate Cancer Drugs Market Size, 2019 (K MT) & (US$ Million)
Table 22. Prostate Cancer Drugs Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Prostate Cancer Drugs Manufacturing Plants
Table 24. Key Manufacturers Prostate Cancer Drugs Market Served
Table 25. Date of Key Manufacturers Enter into Prostate Cancer Drugs Market
Table 26. Key Manufacturers Prostate Cancer Drugs Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Prostate Cancer Drugs Market Size by Type, 2020, (US$ Million)
Table 29. Global Prostate Cancer Drugs Market Size by Type, 2020 (K MT)
Table 30. Global Prostate Cancer Drugs Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Prostate Cancer Drugs Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Prostate Cancer Drugs Market Size by Application, 2020-2021 (K MT)
Table 33. Global Prostate Cancer Drugs Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Prostate Cancer Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Prostate Cancer Drugs Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Prostate Cancer Drugs Market Size, 2019-2021 (K MT)
Table 38. US Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Prostate Cancer Drugs Market Size, 2019-2021 (K MT)
Table 43. Germany Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Prostate Cancer Drugs Market Size, 2019-2021 (K MT)
Table 50. China Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Prostate Cancer Drugs Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. AbbVie Business Overview
Table 58. AbbVie Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Prostate Cancer Drugs Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Astellas Pharma Business Overview
Table 62. Astellas Pharma Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Astellas Pharma Prostate Cancer Drugs Product
Table 64. Astellas Pharma Response to COVID-19 and Related Developments
Table 65. Astra Zeneca Business Overview
Table 66. Astra Zeneca Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Astra Zeneca Prostate Cancer Drugs Product
Table 68. Astra Zeneca Response to COVID-19 and Related Developments
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Johnson & Johnson Prostate Cancer Drugs Product
Table 72. Johnson & Johnson Response to COVID-19 and Related Developments
Table 73. Sanofi Business Overview
Table 74. Sanofi Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Sanofi Prostate Cancer Drugs Product
Table 76. Sanofi Response to COVID-19 and Related Developments
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. GlaxoSmithKline Prostate Cancer Drugs Product
Table 80. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 81. Merck Group Business Overview
Table 82. Merck Group Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Merck Group Prostate Cancer Drugs Product
Table 84. Merck Group Response to COVID-19 and Related Developments
Table 85. Novartis Business Overview
Table 86. Novartis Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Novartis Prostate Cancer Drugs Product
Table 88. Novartis Response to COVID-19 and Related Developments
Table 89. Amgen Business Overview
Table 90. Amgen Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Amgen Prostate Cancer Drugs Product
Table 92. Amgen Response to COVID-19 and Related Developments
Table 93. Bayer HealthCare Business Overview
Table 94. Bayer HealthCare Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bayer HealthCare Prostate Cancer Drugs Product
Table 96. Bayer HealthCare Response to COVID-19 and Related Developments
Table 97. Ferring Pharmaceutical Business Overview
Table 98. Ferring Pharmaceutical Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Ferring Pharmaceutical Prostate Cancer Drugs Product
Table 100. Ferring Pharmaceutical Response to COVID-19 and Related Developments
Table 101. Janssen Pharmaceuticals Business Overview
Table 102. Janssen Pharmaceuticals Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Janssen Pharmaceuticals Prostate Cancer Drugs Product
Table 104. Janssen Pharmaceuticals Response to COVID-19 and Related Developments
Table 105. Endo Pharmaceuticals Business Overview
Table 106. Endo Pharmaceuticals Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Endo Pharmaceuticals Prostate Cancer Drugs Product
Table 108. Endo Pharmaceuticals Response to COVID-19 and Related Developments
Table 109. BMS Business Overview
Table 110. BMS Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. BMS Prostate Cancer Drugs Product
Table 112. BMS Response to COVID-19 and Related Developments
Table 113. Takeda Pharmaceuticals Business Overview
Table 114. Takeda Pharmaceuticals Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Takeda Pharmaceuticals Prostate Cancer Drugs Product
Table 116. Takeda Pharmaceuticals Response to COVID-19 and Related Developments
Table 117. Northwest Biotherapeutics Business Overview
Table 118. Northwest Biotherapeutics Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Northwest Biotherapeutics Prostate Cancer Drugs Product
Table 120. Northwest Biotherapeutics Response to COVID-19 and Related Developments
Table 121. Teva Pharmaceutical Business Overview
Table 122. Teva Pharmaceutical Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Teva Pharmaceutical Prostate Cancer Drugs Product
Table 124. Teva Pharmaceutical Response to COVID-19 and Related Developments
Table 125. Boehringer Ingelheim Business Overview
Table 126. Boehringer Ingelheim Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Boehringer Ingelheim Prostate Cancer Drugs Product
Table 128. Boehringer Ingelheim Response to COVID-19 and Related Developments
Table 129. Foresee Pharmaceuticals Business Overview
Table 130. Foresee Pharmaceuticals Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Foresee Pharmaceuticals Prostate Cancer Drugs Product
Table 132. Foresee Pharmaceuticals Response to COVID-19 and Related Developments
Table 133. Tokai Pharmaceuticals Business Overview
Table 134. Tokai Pharmaceuticals Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Tokai Pharmaceuticals Prostate Cancer Drugs Product
Table 136. Tokai Pharmaceuticals Response to COVID-19 and Related Developments
Table 137. Spectrum Pharmaceuticals Business Overview
Table 138. Spectrum Pharmaceuticals Prostate Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
Table 140. Spectrum Pharmaceuticals Response to COVID-19 and Related Developments
Table 141. Prostate Cancer Drugs Distributors List
Table 142. Prostate Cancer Drugs Customers List
Table 143. Covid-19 Impact on Prostate Cancer Drugs Customers
List of Figures

Figure 1. Prostate Cancer Drugs Product Picture
Figure 2. Prostate Cancer Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Prostate Cancer Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Prostate Cancer Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Prostate Cancer Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Prostate Cancer Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Prostate Cancer Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Prostate Cancer Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Prostate Cancer Drugs Market Size Market Share, 2019-2021
  • Global Kidney Cancer Drugs Market Insights and Forecast to 2026
    Published: 09-Jul-2020        Price: US 3900 Onwards        Pages: 181
    Kidney Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Kidney Cancer Drugs market is segmented into - Angiogenesis Inhibitors - mTOR Inhibitors ......
  • 2015-2025 Global Hydroxycarbamide Market Research by Type, End-Use and Region (COVID-19)
    Published: 09-Jul-2020        Price: US 2900 Onwards        Pages: 112
    Summary Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. The global Hydroxycarbamide market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segmen......
  • Global Gastric Cancer Drug Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
    Published: 09-Jul-2020        Price: US 3200 Onwards        Pages: 163
    According to HJ Research's study, the global Gastric Cancer Drug market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Gastric Cancer Drug market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 202......
  • COVID-19 Outbreak-Global Lamea Oncology/Anti-Cancer Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 09-Jul-2020        Price: US 3660 Onwards        Pages: 107
    The Lamea Oncology/Anti-Cancer Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry.Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise produ......
  • Global Immunotherapy Drugs Market Size, Status and Forecast 2020-2026
    Published: 09-Jul-2020        Price: US 3900 Onwards        Pages: 99
    Immunotherapy Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunotherapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Roche - Merck - Novartis - Johnson & ......
  • COVID-19 Outbreak-Global Immunotherapy Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 09-Jul-2020        Price: US 3660 Onwards        Pages: 126
    A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.Some types of immunotherapy only target certain cells of the immune system.Others affect the immune system in a general way.The Immunotherapy Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees o......
  • Global Oxaliplatin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
    Published: 08-Jul-2020        Price: US 5900 Onwards        Pages: 137
    Oxaliplatin market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Oxaliplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026. Segment by Type, the Oxaliplatin market is segmented into......
  • COVID-19 Outbreak-Global Erbitux Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 07-Jul-2020        Price: US 3660 Onwards        Pages: 121
    The Erbitux market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry de......
  • Global Docetaxel Market Research Report 2020 (Covid-19 Version)
    Published: 05-Jul-2020        Price: US 3500 Onwards        Pages: 138
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - 40 mg/ml - 20 mg/ml - 10 mg/ml By Application - Breast cancer - Non-small cell lung cancer - Prostate cancer - Gastric adenocarcinoma cancer - Head and neck cancer By Company - Sanofi-Aventis - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs